Private Capital Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Hold
55,904
1.23% 19
2026
Q1
$12.2M Hold
55,904
1.39% 18
2025
Q4
$12.8M Sell
55,904
-449
-0.8% -$102K 1.3% 16
2025
Q3
$13M Hold
56,353
1.45% 20
2025
Q2
$10.5M Hold
56,353
1.27% 21
2025
Q1
$11.8M Hold
56,353
1.41% 21
2024
Q4
$10M Hold
56,353
1.19% 23
2024
Q3
$11.1M Sell
56,353
-575
-1% -$107K 1.22% 25
2024
Q2
$9.76M Sell
56,928
-2,657
-4% -$440K 1.09% 24
2024
Q1
$10.8M Sell
59,585
-250
-0.4% -$43.1K 1.35% 22
2023
Q4
$9.27M Sell
59,835
-9,448
-14% -$1.38M 1.41% 20
2023
Q3
$9.78M Sell
69,283
-73
-0.1% -$10.7K 1.51% 17
2023
Q2
$9.34M Sell
69,356
-3,655
-5% -$536K 1.53% 20
2023
Q1
$11.6M Sell
73,011
-20,433
-22% -$3.12M 2.19% 13
2022
Q4
$15.1M Hold
93,444
2.59% 12
2022
Q3
$12.5M Sell
93,444
-75
-0.1% -$10.8K 2.17% 15
2022
Q2
$14.3M Buy
93,519
+25
+0% +$3.82K 2.41% 11
2022
Q1
$15.2M Sell
93,494
-1,250
-1% -$182K 2.21% 11
2021
Q4
$12.8M Sell
94,744
-1,167
-1% -$138K 2.05% 15
2021
Q3
$10.3M Buy
95,911
+1,250
+1% +$143K 1.72% 19
2021
Q2
$10.7M Sell
94,661
-526
-0.6% -$59.2K 1.8% 23
2021
Q1
$10.3M Sell
95,187
-31,695
-25% -$3.39M 1.92% 20
2020
Q4
$13.6M Hold
126,882
2.74% 7
2020
Q3
$11.1M Buy
126,882
+361
+0.3% +$34K 2.58% 9
2020
Q2
$12.4M Sell
126,521
-1,000
-0.8% -$88K 3.22% 10
2020
Q1
$9.72M Buy
127,521
+5,669
+5% +$483K 3.08% 13
2019
Q4
$10.8M Buy
121,852
+950
+0.8% +$78.9K 2.65% 13
2019
Q3
$9.15M Buy
120,902
+8,050
+7% +$552K 2.54% 13
2019
Q2
$8.21M Buy
112,852
+76,892
+214% +$6.04M 2.32% 16
2019
Q1
$2.9M Sell
35,960
-250
-0.7% -$20.5K 0.88% 32
2018
Q4
$3.34M Hold
36,210
1.2% 30
2018
Q3
$3.42M Hold
36,210
0.95% 36
2018
Q2
$3.35M Sell
36,210
-100
-0.3% -$9.77K 1.05% 37
2018
Q1
$3.44M Hold
36,310
1.14% 33
2017
Q4
$3.51M Sell
36,310
-5,110
-12% -$482K 1.22% 30
2017
Q3
$3.68M Sell
41,420
-200
-0.5% -$15.2K 1.26% 29
2017
Q2
$3.02M Buy
41,620
+145
+0.3% +$9.75K 0.98% 33
2017
Q1
$2.7M Buy
41,475
+400
+1% +$25.1K 0.88% 33
2016
Q4
$2.57M Sell
41,075
-25
-0.1% -$1.53K 0.88% 37
2016
Q3
$2.59M Buy
41,100
+400
+1% +$25.9K 0.92% 36
2016
Q2
$2.52M Sell
40,700
-360
-0.9% -$21.9K 0.95% 39
2016
Q1
$2.35M Hold
41,060
1.05% 35
2015
Q4
$2.43M Hold
41,060
1.05% 39
2015
Q3
$2.23M Buy
41,060
+60
+0.1% +$3.91K 0.93% 42
2015
Q2
$2.75M Buy
41,000
+200
+0.5% +$13.1K 0.9% 44
2015
Q1
$2.39M Hold
40,800
0.87% 46
2014
Q4
$2.67M Hold
40,800
1.01% 48
2014
Q3
$2.36M Hold
40,800
0.76% 54
2014
Q2
$2.3M Hold
40,800
0.74% 57
2014
Q1
$2.1M Sell
40,800
-100
-0.2% -$5.05K 0.8% 50
2013
Q4
$2.16M Sell
40,900
-100
-0.2% -$4.92K 0.74% 51
2013
Q3
$1.83M Sell
41,000
-50
-0.1% -$2.22K 0.67% 54
2013
Q2
$1.7M Buy
+41,050
New +$1.8M 0.63% 59

Other funds holding ABBV

Private Capital Advisors's ABBV Position: Q2 2026 in Review

Private Capital Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 55,904 shares worth $14.1M. The position accounts for 1.23% of the portfolio, ranked #19.

Private Capital Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.2M in Q1 2022. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Private Capital Advisors held 55,904 shares of AbbVie worth $14.1M as of Q2 2026.
  • Private Capital Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 1.23% of Private Capital Advisors's portfolio in Q2 2026, its #19 holding.
  • Private Capital Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Private Capital Advisors's AbbVie position peaked at $15.2M in Q1 2022.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.